Pfizer, Moderna to be ready with BA.1-specific COVID-19 boosters | Inquirer News
Close  

Pfizer, Moderna to be ready with BA.1-specific COVID-19 boosters

/ 11:34 AM June 29, 2022
Pfizer, Moderna to be ready with BA.1-specific COVID-19 boosters

Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021. REUTERS FILE PHOTO

Pfizer Inc and Moderna Inc said on Tuesday they will be ready with COVID-19 vaccines designed to combat the BA.1 Omicron variant that was dominant last winter earlier than those designed to target currently dominant subvariants.

Moderna said it would be ready with a “couple of hundred million” of bivalent vaccines designed to combat BA.1 by September, but it would be late October or early November if the vaccine maker needed to design a vaccine to combat the currently dominant BA.4 and BA.5 subvariants.

ADVERTISEMENT

Pfizer said it has a significant amount of BA.1 vaccine produced already and is preparing to produce a large amount of vaccine against BA.4 and BA.5 subvariants. It said either vaccine could be ready for an early October rollout.

RELATED STORIES

FEATURED STORIES

Omicron BA.2.12.1 in PH: What you need to know

US FDA advisers recommend change to COVID vaccine composition for fall

Omicron-based COVID shots improve response vs that variant – Pfizer-BioNTech

US medical experts call for Omicron-specific COVID boosters

Subscribe to our daily newsletter


Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: COVID-19 Vaccines, Moderna, Omicron subvariants, Pfizer
For feedback, complaints, or inquiries, contact us.



© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.